Group 1: Bristol-Myers Squibb - Bristol-Myers Squibb reported third-quarter 2025 revenues of $12.22 billion, exceeding the consensus estimate of $11.81 billion, representing a 3% year-over-year increase [1] - Shares of Bristol-Myers Squibb rose 1.2% to settle at $47.26 [5] Group 2: Baidu and Alibaba - Jim Cramer recommended Alibaba as the top choice for Chinese stocks, followed by Baidu [1] - Baidu's third-quarter financial results will be reported on Nov. 18 [1] - Baidu shares gained 5.1% to close at $132.32 [5] - Alibaba shares fell 0.3% to settle at $165.89 [5] Group 3: Brinker International - Brinker International reported quarterly earnings of $1.93 per share, beating analysts' estimate of $1.77, with profit more than doubling from $0.95 a year earlier [2][3] - Revenue rose 18.4% to $1.35 billion from $1.14 billion in the same period a year ago, slightly ahead of the expected $1.33 billion [3] - Shares of Brinker gained 3.9% to close at $106.61 [5] Group 4: New Era Energy & Digital - New Era Energy & Digital announced a land option purchase agreement for approximately 3,500 acres in Lea County, New Mexico, for a large-scale AI data center campus [2][3] - The company received a positive endorsement from Jim Cramer regarding its speculative potential [2] - New Era Energy & Digital shares fell 5.3% to settle at $5.09 [5]
Jim Cramer Is Backing Off Bristol-Myers; Baidu, Alibaba Are Good - Alibaba Gr Hldgs (NYSE:BABA), Baidu (NASDAQ:BIDU)